Published in J Clin Microbiol on April 09, 2008
Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS One (2009) 1.32
Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia. Saudi J Gastroenterol (2013) 1.02
High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. J Clin Microbiol (2014) 1.02
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World J Gastroenterol (2014) 0.98
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes. BMC Infect Dis (2014) 0.98
HCV infection among Saudi population: high prevalence of genotype 4 and increased viral clearance rate. PLoS One (2012) 0.97
Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0. J Clin Microbiol (2013) 0.96
Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping. J Clin Microbiol (2015) 0.93
Hepatitis C virus: Virology, diagnosis and treatment. World J Hepatol (2015) 0.89
Correlation of the 5'untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping. Int J Mol Epidemiol Genet (2010) 0.88
Important factors in reliable determination of hepatitis C virus genotype by use of the 5' untranslated region. J Clin Microbiol (2013) 0.87
Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging. World J Gastroenterol (2014) 0.87
A novel hepatitis C virus genotyping method based on liquid microarray. PLoS One (2010) 0.86
Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6. J Clin Microbiol (2014) 0.85
Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence. J Clin Microbiol (2010) 0.84
Hepatitis C genotype 6: A concise review and response-guided therapy proposal. World J Hepatol (2013) 0.82
Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form. Int J Mol Sci (2016) 0.81
Distribution of Hepatitis C Virus Genotypes in Bahrain. Hepat Mon (2015) 0.80
High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment. Hepatol Res (2015) 0.78
HCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasma. PLoS One (2015) 0.78
Evaluation of multiplex nested polymerase chain reaction for routine hepatitis C virus genotyping in egyptian patients. Hepat Mon (2012) 0.77
Hepatitis C Genotype Prevalence in Monastir Region, Tunisia: Correlation between 5' Untranslated Region (5'UTR), Non-structural 5B (NS5B), and Core Sequences in HCV Subtyping. Curr Microbiol (2016) 0.76
Assessment of a novel automatic real-time PCR assay on the Cobas4800 analyzer as a screening platform for HCV genotyping in clinical practice: comparison with massive sequencing. J Clin Microbiol (2016) 0.75
Advances in the Diagnosis and Monitoring of Hepatitis C Virus Infection. Gastroenterology Res (2013) 0.75
Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6. J Clin Microbiol (2016) 0.75
Evaluation of the Abbott Real Time HCV genotype II assay for Hepatitis C virus genotyping. Pak J Med Sci (2015) 0.75
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology (2005) 9.39
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat (1999) 6.42
National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002. Hepatology (2002) 5.16
Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol (1996) 3.22
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91
National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hepatology (2002) 2.19
Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol (1999) 1.80
Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b. J Clin Microbiol (2002) 1.78
Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus. J Infect Dis (2000) 1.76
Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol (2005) 1.68
Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis (2003) 1.63
Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region. J Clin Microbiol (2003) 1.62
Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene). J Clin Microbiol (2001) 1.56
Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res (2003) 1.47
Laboratory assays for diagnosis and management of hepatitis C virus infection. J Clin Microbiol (2002) 1.46
Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods (2003) 1.32
Subtyping of hepatitis C virus isolates by a line probe assay using hybridization. J Clin Microbiol (1995) 1.25
Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol (2006) 1.16
Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions. J Clin Microbiol (2006) 1.09
Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping. J Med Virol (2001) 1.06
Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays. J Hepatol (1997) 1.04
Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy. World J Gastroenterol (2006) 1.01
Molecular methods of hepatitis C genotyping. Expert Rev Mol Diagn (2005) 1.00
Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirin. J Infect Dis (2004) 0.95
Hepatitis C: an update. Swiss Med Wkly (2001) 0.94
Slow viral dynamics of hepatitis C virus genotype 4. J Viral Hepat (2003) 0.93
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group. Scand J Infect Dis (1997) 0.89
Antiviral treatment of hepatitis C: present status and future prospects. J Infect Chemother (2006) 0.87
Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin. J Hepatol (2003) 0.85
Hepatitis C virus genotypes, HLA-DRB alleles and their response to interferon-alpha and ribavirin in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int (2005) 0.81
Genotyping of hepatitis C virus-comparison of three assays. J Clin Virol (2003) 0.78
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology (2005) 9.39
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med (2005) 6.33
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol (2008) 3.73
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst (2004) 3.20
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77
Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes. Eur J Gastroenterol Hepatol (2006) 2.47
Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol (2005) 2.35
A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis (2005) 2.28
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. J Clin Oncol (2013) 2.28
Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol (2009) 2.21
Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol (2006) 2.12
RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol (2009) 2.06
A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucleic Acids Res (2009) 2.06
Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients. Gastroenterology (2007) 2.03
Hantaviruses: immunology, treatment, and prevention. Viral Immunol (2004) 2.00
HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology (2004) 1.83
Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay. J Clin Microbiol (2002) 1.81
VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch Virol (2012) 1.78
Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy. Hepatology (2003) 1.78
Ancient papillomavirus-host co-speciation in Felidae. Genome Biol (2007) 1.75
Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh. Emerg Infect Dis (2007) 1.73
A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology (2006) 1.65
A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification. J Virol (2004) 1.64
Are human P[14] rotavirus strains the result of interspecies transmissions from sheep or other ungulates that belong to the mammalian order Artiodactyla? J Virol (2009) 1.62
Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmission. J Virol (2006) 1.61
Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein. J Virol (2005) 1.60
A commutable cytomegalovirus calibrator is required to improve the agreement of viral load values between laboratories. Clin Chem (2009) 1.59
Multicenter evaluation of the Bayer VERSANT HIV-1 RNA 3.0 assay: analytical and clinical performance. J Clin Virol (2002) 1.58
Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol Biol Evol (2010) 1.57
Text4baby: development and implementation of a national text messaging health information service. Am J Public Health (2012) 1.53
Relating increasing hantavirus incidences to the changing climate: the mast connection. Int J Health Geogr (2009) 1.48
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens. BMC Cancer (2014) 1.48
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med (2009) 1.48
Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein. J Virol (2004) 1.48
Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma. Hepatology (2003) 1.47
Search for polymorphisms in the genes for herpesvirus entry mediator, nectin-1, and nectin-2 in immune seronegative individuals. J Infect Dis (2001) 1.47
Animal papillomaviruses. Virology (2013) 1.47
Characterization of a novel P[25],G11 human group a rotavirus. J Clin Microbiol (2005) 1.46
G8 rotavirus strains isolated in the Democratic Republic of Congo belong to the DS-1-like genogroup. J Clin Microbiol (2006) 1.46
Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants. J Clin Microbiol (2003) 1.43
Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations. PLoS Pathog (2009) 1.43
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun (2004) 1.42
Evolutionary history of the closely related group 2 coronaviruses: porcine hemagglutinating encephalomyelitis virus, bovine coronavirus, and human coronavirus OC43. J Virol (2006) 1.42
Molecular typing and epidemiology of enteroviruses identified from an outbreak of aseptic meningitis in Belgium during the summer of 2000. J Med Virol (2003) 1.40
Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons. J Clin Microbiol (2007) 1.39
Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J Clin Microbiol (2011) 1.33
Genotype constellation and evolution of group A rotaviruses infecting humans. Curr Opin Virol (2012) 1.29
Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine (2010) 1.28
Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique. Pediatr Transplant (2004) 1.26
Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir. J Clin Microbiol (2006) 1.25
Cattle pathogen tritrichomonas foetus (Riedmüller, 1928) and pig commensal Tritrichomonas suis (Gruby & Delafond, 1843) belong to the same species. J Eukaryot Microbiol (2002) 1.25
Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus. J Infect Dis (2002) 1.23
Analysis of the serotype and genotype correlation of VP1 and the 5' noncoding region in an epidemiological survey of the human enterovirus B species. J Clin Microbiol (2004) 1.22
Text4Baby: using text messaging to improve maternal and newborn health. Nurs Womens Health (2011) 1.21
Cloning and genomic characterization of Felis domesticus papillomavirus type 1. Virology (2002) 1.19
A proposal for new criteria for the classification of hantaviruses, based on S and M segment protein sequences. Infect Genet Evol (2009) 1.18
Isolation and cloning of the raccoon (Procyon lotor) papillomavirus type 1 by using degenerate papillomavirus-specific primers. J Gen Virol (2005) 1.16
Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol (2006) 1.16
Strong association between genotype F and hepatitis B virus (HBV) e antigen-negative variants among HBV-infected argentinean blood donors. J Clin Microbiol (2004) 1.14
Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. J Hepatol (2004) 1.12
Chromatography paper strip sampling of enteric adenoviruses type 40 and 41 positive stool specimens. Virol J (2005) 1.11
Avian papillomaviruses: the parrot Psittacus erithacus papillomavirus (PePV) genome has a unique organization of the early protein region and is phylogenetically related to the chaffinch papillomavirus. BMC Microbiol (2002) 1.11
A pancoronavirus RT-PCR assay for detection of all known coronaviruses. Methods Mol Biol (2008) 1.11
Two out of the 11 genes of an unusual human G6P[6] rotavirus isolate are of bovine origin. J Gen Virol (2008) 1.10
A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene. J Virol Methods (2005) 1.10
Acute mountain sickness is associated with sleep desaturation at high altitude. Respirology (2004) 1.10
Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) (2010) 1.10
Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions. J Clin Microbiol (2006) 1.09
GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics (2009) 1.09
Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1. J Infect Dis (2003) 1.09
Genomic characterization of novel dolphin papillomaviruses provides indications for recombination within the Papillomaviridae. Virology (2008) 1.08
Developing vasculature and stroma in engineered human myocardium. Tissue Eng Part A (2011) 1.07
Prognostic factors in severe exacerbation of chronic hepatitis B. Clin Infect Dis (2003) 1.07
Lung lining fluid glutathione attenuates IL-13-induced asthma. Am J Respir Cell Mol Biol (2007) 1.06
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol (2006) 1.06
Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort. J Virol Methods (2007) 1.05
The health and economic burden of rotavirus disease in Belgium. Eur J Pediatr (2008) 1.05
Genomic characterization of a novel virus found in papillomatous lesions from a southern brown bandicoot (Isoodon obesulus) in Western Australia. Virology (2008) 1.05
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer. Clin Cancer Res (2014) 1.04
Multiple reassortment and interspecies transmission events contribute to the diversity of feline, canine and feline/canine-like human group A rotavirus strains. Infect Genet Evol (2011) 1.03
No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: impact of resistant minority variants on efficacy of low genetic barrier drugs. J Clin Virol (2007) 1.03
Recent approaches in hantavirus vaccine development. Expert Rev Vaccines (2009) 1.03
Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E. J Clin Microbiol (2005) 1.02
Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Vaccine (2010) 1.01
Comparison of the FilmArray RP, Verigene RV+, and Prodesse ProFLU+/FAST+ multiplex platforms for detection of influenza viruses in clinical samples from the 2011-2012 influenza season in Belgium. J Clin Microbiol (2013) 1.00
Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory. J Virol Methods (2004) 0.99
Predominance of rotavirus G9 genotype in children hospitalized for rotavirus gastroenteritis in Belgium during 1999-2003. J Clin Virol (2005) 0.99
High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users. J Med Virol (2004) 0.99
Novel papillomavirus isolated from the oral mucosa of a polar bear does not cluster with other papillomaviruses of carnivores. Vet Microbiol (2007) 0.98
Isolation and cloning of a papillomavirus from a North American porcupine by using multiply primed rolling-circle amplification: the Erethizon dorsatum papillomavirus type 1. Virology (2005) 0.98